KalGene Pharmaceuticals company

KalGene Pharmaceuticals, Inc. is a privately held company working in partnership with many of North America and Europe’s leading clinician-scientists and academic institutions. KalGene is focused on the development of targeted therapeutics and companion diagnostics. Its programs are aimed at improving clinical and survival outcomes through the use of personalized medicine. Personalized medicine seeks to predict which patients will respond to a particular therapy in advance of treatment. This prediction allows physicians to prescribe treatment according to an individual’s specific biological signature, or needs.
Technology: P4 Medicine
Industry: Health Care
Headquarters: Toronto, Ontario, Canada
Founded Date: 2007-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Total Funding: $250K
Estimated Revenue: Less than $1M
Last Funding Type: Angel

Visit Website
info@kalgene.com
https://twitter.com/xesto_io
Register and Claim Ownership